Dosimetric evaluation of analytic anisotropic algorithm and Acuros XB algorithm using in-house developed heterogeneous thorax phantom and homogeneous slab phantom for stereotactic body radiation therapy technique

Abstract

To perform patient-specific quality assurance (QA), the accuracy of the dose calculation algorithm is vital, especially in the lung cancer stereotactic body radiation therapy (SBRT). The present study is based on the evaluation of two widely used algorithms, analytical anisotropic algorithm (AAA) and Acuros XB (AXB) inside the in-house developed heterogeneous thorax phantom (HTP) and a homogeneous slab phantom (HSP) simultaneously. To evaluate dosimetric differences between the two algorithms, point dose measurement was performed for pretreatment QA plans of 35 lung cancer patients by keeping the same monitor units and beam angles as those for the actual patient treatment. The dose was calculated on the Eclipse treatment planning system inside both the medium by using both AAA and AXB algorithms. Plans were delivered on the Edge linear accelerator (LA) (Varian Medical Systems, Palo Alto, CA, USA), and measurements were taken by using a 0.01 cc ion chamber and DOSE1 electrometer. Statistical analysis was performed on the observed data set, and percentage (%) variations between the measured and planned doses were calculated and analyzed. The mean % variations between the measured and planned doses inside HTP for all QA plans were found to be 2.61 (standard deviation [SD]: 0.66) and 2.19 (SD: 0.64) for AAA and AXB algorithms, respectively. Whereas, inside HSP, it was found to be 1.79 (SD: 0.74) and 1.64 (SD: 0.70) for AAA and AXB algorithms, respectively. The mean % difference between the measured dose and the planned dose was derived to be statistically significant for HTP, however, it was found to be statistically insignificant inside the HSP at P < 0.01. The Pearson's correlation coefficient test showed a strong positive correlation between the measured dose and the planned dose for both AAA and AXB inside HTP as well for HSP. The results obtained from this study showed that as the actual patient body is heterogeneous, thus to get more realistic results, patient-specific QA must be performed inside the heterogeneous phantom instead of homogeneous. Moreover, in the homogeneous medium, both the algorithms predict the dose efficiently, however, in heterogeneous medium, AAA over/under predicts the dose, whereas AXB shows good concurrence with measurements.

Keywords

• acuros xb
• analytical anisotropic algorithm
• heterogeneous thorax phantom
• homogeneous slab phantom
• patient-specific quality assurance